| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.CIR.101.22.2554 |
| P698 | PubMed publication ID | 10840004 |
| P2093 | author name string | Z Wang | |
| S Chen | |||
| R S Meidell | |||
| R V Shohet | |||
| R H Unger | |||
| Y T Zhou | |||
| P A Grayburn | |||
| P433 | issue | 22 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microbubble | Q6839290 |
| P304 | page(s) | 2554-6 | |
| P577 | publication date | 2000-06-06 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Echocardiographic destruction of albumin microbubbles directs gene delivery to the myocardium | |
| P478 | volume | 101 |
| Q30448009 | A method to co-encapsulate gas and drugs in liposomes for ultrasound-controlled drug delivery |
| Q30475161 | A visible, targeted high-efficiency gene delivery and transfection strategy |
| Q30439139 | Acoustic attenuation by contrast agent microbubbles in superficial tissue markedly diminishes petechiae bioeffects in deep tissue |
| Q39439335 | Activation of microbubbles by short-pulsed ultrasound enhances the cytotoxic effect of cis-diamminedichloroplatinum (II) in a canine thyroid adenocarcinoma cell line in vitro |
| Q30458491 | Advances in ultrasound mediated gene therapy using microbubble contrast agents |
| Q39033867 | Albumin acts like transforming growth factor β1 in microbubble-based drug delivery |
| Q64085331 | Antisense oligonucleotides for the treatment of cardiomyopathy in Duchenne muscular dystrophy |
| Q35133701 | Apoptosis of THP-1 derived macrophages induced by sonodynamic therapy using a new sonosensitizer hydroxyl acetylated curcumin. |
| Q93017847 | Applications of Ultrasound to Stimulate Therapeutic Revascularization |
| Q45878832 | Augmentation of AAV-mediated cardiac gene transfer after systemic administration in adult rats |
| Q51483161 | Augmentation of cardiac protein delivery using ultrasound targeted microbubble destruction. |
| Q30361750 | Biophysical insight into mechanisms of sonoporation |
| Q37194005 | Bone marrow mononuclear stem cells: potential in the treatment of myocardial infarction. |
| Q34409721 | Cardiac Gene Therapy |
| Q37811189 | Cardiac gene therapy with SERCA2a: From bench to bedside |
| Q30479697 | Cardiovascular therapeutic uses of targeted ultrasound contrast agents |
| Q30450076 | Cationic versus neutral microbubbles for ultrasound-mediated gene delivery in cancer |
| Q40026377 | Chapter 7. Molecular imaging of tumor vasculature |
| Q30489686 | Clinical applications of perfluorocarbon nanoparticles for molecular imaging and targeted therapeutics. |
| Q35042291 | Combination of interventional adenovirus-p53 introduction and ultrasonic irradiation in the treatment of liver cancer |
| Q45889026 | Combined shock-wave and immunogene therapy of mouse melanoma and renal carcinoma tumors |
| Q39799619 | Comparative analysis of gene transfer to human and rat retinal pigment epithelium cell line by a combinatorial use of recombinant adeno- associated virus and ultrasound or/and microbubbles |
| Q64887219 | Concurrent Osteosarcoma Theranostic Strategy Using Contrast-Enhanced Ultrasound and Drug-Loaded Bubbles. |
| Q35762037 | Contrast echocardiography: new agents |
| Q37634390 | Contrast enhanced ultrasound imaging |
| Q73400336 | DNA transfer and cell killing in epidermoid cells by diagnostic ultrasound activation of contrast agent gas bodies in vitro |
| Q40718907 | DNA-loaded albumin microbubbles enhance ultrasound-mediated transfection in vitro |
| Q46859128 | Disposition of perfluorobutane in rats after intravenous injection of Sonazoid |
| Q94947602 | Effect of high-intensity ultrasound-targeted microbubble destruction on perfusion and function of the rat heart assessed by pinhole-gated SPECT |
| Q39842450 | Effect of sonoporation on cationic liposome-mediated IFNbeta gene therapy for metastatic hepatic tumors of murine colon cancer |
| Q47664558 | Effects of ultrasound-targeted microbubble destruction on cardiac gene expression |
| Q30502097 | Efficient gene delivery to pancreatic islets with ultrasonic microbubble destruction technology |
| Q30439332 | Enhancement of adenovirus delivery after ultrasound-stimulated therapy in a cancer model. |
| Q30467947 | Enhancement of vancomycin activity against biofilms by using ultrasound-targeted microbubble destruction |
| Q30454544 | Evaluation of methods for sizing and counting of ultrasound contrast agents |
| Q30310252 | Evolving applications for contrast ultrasound |
| Q39659049 | Experimental Research on Wild-type p53 Plasmid Transfected into Retinoblastoma Cells and Tissues using an Ultrasound Microbubble Intensifier |
| Q26781322 | Facilitation of Drug Transport across the Blood-Brain Barrier with Ultrasound and Microbubbles |
| Q30463703 | Feasibility and effect of ultrasound microbubble-mediated wild-type p53 gene transfection of HeLa cells |
| Q45864560 | Focused ultrasound (HIFU) induces localized enhancement of reporter gene expression in rabbit carotid artery |
| Q36617570 | Gene targeting in ischemic heart disease and failure: translational and clinical studies |
| Q35011746 | Gene therapy progress and prospects: nonviral vectors. |
| Q50940162 | Granulocyte colony-stimulating factor facilitates the angiogenesis induced by ultrasonic microbubble destruction. |
| Q30480314 | Growth and dissolution of an encapsulated contrast microbubble: effects of encapsulation permeability |
| Q46206400 | High-efficiency endovascular gene delivery via therapeutic ultrasound |
| Q30499018 | Identification and characterization of a novel adhesin unique to oral fusobacteria |
| Q51039381 | Impact of microbubbles on shock wave-mediated DNA uptake in cells in vitro. |
| Q44763978 | Impact of myocardial contrast echocardiography on vascular permeability: comparison of three different contrast agents |
| Q78454283 | In vitro transfer of antisense oligodeoxynucleotides into coronary endothelial cells by ultrasound |
| Q50510920 | In vivo gene transfer into the ocular ciliary muscle mediated by ultrasound and microbubbles. |
| Q30308737 | Influence of injection site, microvascular pressure and ultrasound variables on microbubble-mediated delivery of microspheres to muscle |
| Q30362133 | Intravascular ultrasound catheter to enhance microbubble-based drug delivery via acoustic radiation force. |
| Q30453595 | Introduction to the ultrasound targeted microbubble destruction technique |
| Q74574389 | Irradiation with ultrasound of low output intensity increased chemosensitivity of subcutaneous solid tumors to an anti-cancer agent |
| Q44239730 | Lithotripter shock waves with cavitation nucleation agents produce tumor growth reduction and gene transfer in vivo |
| Q38423785 | Mechanical index |
| Q40067662 | Mechanistic Insight into Sonoporation with Ultrasound-Stimulated Polymer Microbubbles |
| Q24631069 | Microbubble Compositions, Properties and Biomedical Applications |
| Q90346534 | Microbubble Formulations: Synthesis, Stability, Modeling and Biomedical Applications |
| Q24525212 | Microbubble contrast agents: a new era in ultrasound |
| Q30490368 | Microbubble destruction with ultrasound augments neovascularisation by bone marrow cell transplantation in rat hind limb ischaemia |
| Q40552180 | Microbubble-enhanced sonoporation: efficient gene transduction technique for chick embryos |
| Q30433669 | Microbubbles in medical imaging: current applications and future directions |
| Q30438994 | Microbubbles in ultrasound-triggered drug and gene delivery |
| Q78709487 | Microbubbles induce renal hemorrhage when exposed to diagnostic ultrasound in anesthetized rats |
| Q30312262 | Molecular imaging with contrast ultrasound and targeted microbubbles |
| Q30407070 | Multimodality and nanoparticles in medical imaging |
| Q30476445 | Multimodality molecular imaging of CD105 (Endoglin) expression |
| Q46182331 | Myocardial injury induced by ultrasound-targeted microbubble destruction: evidence for the contribution of myocardial ischemia |
| Q51209977 | Myocardium-targeted delivery of endothelial progenitor cells by ultrasound-mediated microbubble destruction improves cardiac function via an angiogenic response. |
| Q33295132 | Nanomechanical probing of microbubbles using the atomic force microscope |
| Q30461404 | New approaches in small animal echocardiography: imaging the sounds of silence |
| Q50725899 | Nitric oxide delivery by ultrasonic cracking: some limitations. |
| Q64377523 | Optimization of ultrasound parameters for cardiac gene delivery of adenoviral or plasmid deoxyribonucleic acid by ultrasound-targeted microbubble destruction |
| Q45925935 | Partial restoration of left ventricular systolic function by asPLB gene transfer using ultrasound-mediated microbubble destruction. |
| Q34690229 | Pharmaceutical strategies utilizing recombinant human serum albumin |
| Q30412855 | Physical energy for drug delivery; poration, concentration and activation. |
| Q28488824 | Potentiation of scutellarin on human tongue carcinoma xenograft by low-intensity ultrasound |
| Q30475818 | Preclinical molecular imaging of tumor angiogenesis. |
| Q36076342 | Preparation of human hepatocellular carcinoma-targeted liposome microbubbles and their immunological properties |
| Q30459677 | Production of uniformly sized serum albumin and dextrose microbubbles |
| Q48447157 | Refinement of in vivo surgical procedures for cardiac gene and cell transfer in rats. |
| Q58564835 | Reverse engineering the ultrasound contrast agent |
| Q30454924 | Scaled-Up Production of Monodisperse, Dual Layer Microbubbles Using Multi-Array Microfluidic Module for Medical Imaging and Drug Delivery |
| Q73383475 | Seizing the science of ultrasound: beyond imaging and into physiology and therapeutics |
| Q30361646 | Smart micro/nanoparticles in stimulus-responsive drug/gene delivery systems. |
| Q30480947 | Sonoporation-mediated gene transfer into adult rat dorsal root ganglion cells |
| Q50452884 | Spatial distribution of ultrasound targeted microbubble destruction increases cardiac transgene expression but not capillary permeability |
| Q42916882 | Stability analysis of an encapsulated microbubble against gas diffusion |
| Q50661475 | Study of sonoporation dynamics affected by ultrasound duty cycle. |
| Q30502039 | Synergistic effect of ultrasound and PEI on DNA transfection in vitro |
| Q44776900 | Systemic targeted delivery of antisense with perflourobutane gas microbubble carrier reduced neointimal formation in the porcine coronary restenosis model |
| Q44242295 | Target and therapeutic microbubbles |
| Q50503729 | Targeted endothelial gene delivery by ultrasonic destruction of magnetic microbubbles carrying lentiviral vectors. |
| Q30312032 | Targeted tissue transfection with ultrasound destruction of plasmid-bearing cationic microbubbles |
| Q48810713 | Targeted ultrasound contrast imaging of matrix metalloproteinase-2 in ischemia-reperfusion rat model: ex vivo and in vivo studies |
| Q39039959 | Targeting TRAF3IP2 by Genetic and Interventional Approaches Inhibits Ischemia/Reperfusion-induced Myocardial Injury and Adverse Remodeling |
| Q45882823 | Targeting of VEGF-mediated angiogenesis to rat myocardium using ultrasonic destruction of microbubbles |
| Q33610596 | Tertiary-amine functionalized polyplexes enhanced cellular uptake and prolonged gene expression |
| Q52546636 | The disappearance of ultrasound contrast bubbles: observations of bubble dissolution and cavitation nucleation. |
| Q24804233 | The use of microbubbles to target drug delivery |
| Q38859630 | Therapeutic potential of low-intensity ultrasound (part 1): thermal and sonomechanical effects |
| Q38859636 | Therapeutic potential of low-intensity ultrasound (part 2): biomolecular effects, sonotransfection, and sonopermeabilization |
| Q39566078 | Therapeutic ultrasonic microbubbles carrying paclitaxel and LyP-1 peptide: preparation, characterization and application to ultrasound-assisted chemotherapy in breast cancer cells. |
| Q40370131 | Therapeutic ultrasound-mediated DNA to cell and nucleus: bioeffects revealed by confocal and atomic force microscopy |
| Q45856463 | Transthoracic direct current shock facilitates intramyocardial transfection of naked plasmid DNA infused via coronary vessels in canines. |
| Q50250740 | Tumor growth reduction and DNA transfer by cavitation-enhanced high-intensity focused ultrasound in vivo |
| Q30500618 | Ultrasonic contrast agent shell rupture detected by inertial cavitation and rebound signals |
| Q30502960 | Ultrasonic drug delivery--a general review |
| Q103825405 | Ultrasound Microbubble-Mediated VHL Regulates the Biological Behavior of Ovarian Cancer Cells |
| Q30429594 | Ultrasound and microbubble guided drug delivery: mechanistic understanding and clinical implications |
| Q43274235 | Ultrasound and microbubble-induced intra- and intercellular bioeffects in primary endothelial cells |
| Q30482585 | Ultrasound contrast microbubbles in imaging and therapy: physical principles and engineering |
| Q24800403 | Ultrasound imaging versus morphopathology in cardiovascular diseases. Coronary collateral circulation and atherosclerotic plaque |
| Q50467347 | Ultrasound targeted microbubble destruction increases capillary permeability in hepatomas. |
| Q30478731 | Ultrasound-enhanced drug transport and distribution in the brain |
| Q51655897 | Ultrasound-induced encapsulated microbubble phenomena. |
| Q40292767 | Ultrasound-mediated gene transfection: problems to be solved and future possibilities |
| Q30416117 | Ultrasound-mediated vascular gene transfection by cavitation of endothelial-targeted cationic microbubbles |
| Q30438366 | Ultrasound-microbubble-induced neovascularization in mouse skeletal muscle |
| Q45886640 | Ultrasound-targeted microbubble destruction enhances AAV-mediated gene transfection in human RPE cells in vitro and rat retina in vivo |
| Q30446500 | Ultrasound-targeted microbubble destruction to deliver siRNA cancer therapy. |
| Q39484814 | Use of EPR and FTIR to detect biological effects of ultrasound and microbubbles on a fibroblast cell line |
| Q30496586 | Use of ultrasound pulses combined with Definity for targeted blood-brain barrier disruption: a feasibility study |
| Q45866017 | Use of ultrasound to enhance nonviral lung gene transfer in vivo |
| Q30455612 | Vascular endothelial growth factor as an anti-angiogenic target for cancer therapy |
| Q80162439 | [Sonopermeabilization: therapeutic alternative with ultrasound and microbubbles] |
Search more.